Last update 24 May 2025

Fluoxymesterone

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
11β,17β-Dihydroxy-9α-fluoro-17α-methyl-4-androster-3-one, 17α-Methyl-9α-fluoro-11β-hydroxytesterone, 9-Fluoro-11β,17β-dihydroxy-17-methylandrost-4-en-3-one
+ [18]
Target
Action
agonists
Mechanism
AR agonists(Androgen Receptor agonists)
Inactive Indication
Originator Organization
Active Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (15 Oct 1956),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC20H29FO3
InChIKeyYLRFCQOZQXIBAB-RBZZARIASA-N
CAS Registry76-43-7

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Breast Cancer
United States
15 Oct 1956
Delayed Puberty
United States
15 Oct 1956
Hypogonadism
United States
15 Oct 1956
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
Estrogen receptor positive breast cancer
estrogen receptor-positive | androgen receptor
103
quzkbemvzd(zkpfycbfmg) = toxicity in 14 patients sgnflhpflb (supximnlkw )
Positive
15 Feb 2017
Phase 3
1
Visual Examination+OraTest
uhefvozlna(dihphchimn) = kgevmtodbm adsmkuvysn (ydhakezvgj, mrlveyzzpp - kyzxeedvtv)
-
18 Jan 2010
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free